LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.11 27.76 1666 3331 0.5001 0.8091
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.11 27.76 1710 3331 0.5133 0.8159
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.11 27.76 2021 3331 0.6066 0.8604
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.11 27.76 2064 3331 0.6195 0.8661
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 42.81 27.76 1471 3596 0.4090 0.7608
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 42.81 27.76 1510 3596 0.4199 0.7674
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 42.81 27.76 1746 3596 0.4855 0.8043
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 42.81 27.76 1783 3596 0.4958 0.8097
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 42.81 27.76 2117 3596 0.5887 0.8545
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 42.81 27.76 2151 3596 0.5981 0.8588
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 44.52 27.76 1540 3884 0.3965 0.7566
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 44.52 27.76 1573 3884 0.4050 0.7618
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 44.52 27.76 1820 3884 0.4686 0.7982
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 44.52 27.76 1869 3884 0.4812 0.8049
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 44.52 27.76 2236 3884 0.5757 0.8509
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 44.52 27.76 2263 3884 0.5826 0.8540
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 46.22 27.76 1610 4125 0.3903 0.7555
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 46.22 27.76 1650 4125 0.4000 0.7615
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 46.22 27.76 1890 4125 0.4582 0.7950
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 46.22 27.76 1934 4125 0.4689 0.8007
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 46.22 27.76 2266 4125 0.5493 0.8407
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 46.22 27.76 2312 4125 0.5605 0.8458
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.93 27.76 1665 4421 0.3766 0.7501
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.93 27.76 1718 4421 0.3886 0.7576
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.93 27.76 1977 4421 0.4471 0.7916
MN20160318_Q01
H12